Dysregulation of the gut microbiota can also contribute to the development or progression of sarcopenia and obesity by altering the expression of myostatin and atrogin-1, as well as disrupting the signaling between the enteric nervous system and the brain. Here, FBXO32 is linked to obesity disorder.